Manufacturing

We have the unique capability to leverage multiple manufacturing facilities for our research and development and commercial manufacturing activities.

Manufacturing

Vaccine manufacturing capabilities to flexibly meet global demand

We have two in-house manufacturing facilities: a good manufacturing practice (GMP)-certified commercial manufacturing in Changxing, Zhejiang province, China, and a research and development and pilot manufacturing facility in Chengdu, Sichuan province, China.

Changxing Commercial Manufacturing Facility

Changxing Commercial Manufacturing Facility

Our in-house, commercial-ready vaccines manufacturing facility in Changxing, Zhejiang province has achieved good manufacturing practice status for the production of SCB-2019 (CpG 1018/Alum) in China and is now supporting the commercial production of SCB-2019 (CpG 1018/Alum).

Chengdu R&D and Pilot Manufacturing Facility

Chengdu R&D and Pilot Manufacturing Facility

Located in Chengdu, Sichuan province, our R&D and pilot manufacturing facility supplies materials for our pre-clinical and early-stage clinical trials. It occupies approximately 3,300 square meters and contains a 200 liter single-use and 150 liter stainless steel bioreactor capacity as well as multiple pilot-scale drug product filling lines.